Cigna Group (NYSE:CI) Shares Down 5.8% – Time to Sell?

Shares of Cigna Group (NYSE:CI – Get Free Report) traded down 5.8% during mid-day trading on Thursday. The company traded as low as $269.26 and last traded at $268.8550. 929,986 shares traded hands during trading, a decline of 44% from the average daily volume of 1,670,066 shares. The stock had previously closed at $285.37.

Recent Cigna Group Headlines

Here are a few of the latest headlines about CI:

  • Positive Sentiment: RBC raised its price target to $346 from $337 and reiterated an “Outperform” rating, signaling continued analyst confidence. RBC price-target update
  • Neutral Sentiment: Cigna announced a three-year community-impact strategy supporting youth mental health, veterans, and people with complex health conditions. The initiative highlights corporate commitments but is unlikely to materially affect near-term earnings. Community strategy announcement
  • Negative Sentiment: Investors are reacting to CMS’s proposed CRUSH rule, which would expand oversight and audits across government healthcare programs, including Medicare Advantage and Part D. The proposal raises potential compliance and repayment concerns for the managed-care sector. Cigna sold its Medicare Advantage, Part D, and related businesses in 2025, so its direct exposure is more limited; the selling may largely reflect sector-wide pressure. CMS rule and managed-care stocks

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Sanford C. Bernstein upped their price objective on Cigna Group from $387.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 11th. Piper Sandler cut their price target on Cigna Group from $370.00 to $360.00 and set an “overweight” rating for the company in a report on Thursday, November 12th. Royal Bank Of Canada upped their price target on Cigna Group from $337.00 to $346.00 and gave the stock an “outperform” rating in a research report on Thursday. Barclays upped their price target on Cigna Group from $310.00 to $320.00 and gave the stock an “equal weight” rating in a research report on Monday, November 9th. Finally, Evercore initiated coverage on Cigna Group in a research note on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price objective on the stock. Fourteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $337.35.

Read Our Latest Research Report on CI

Cigna Group Trading Down 3.9%

The stock has a market capitalization of $72.23 billion, a PE ratio of 12.10, a PEG ratio of 1.10 and a beta of 0.25. The stock’s 50 day moving average price is $288.37 and its 200-day moving average price is $283.00. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66.

Cigna Group (NYSE:CI – Get Free Report) last released its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. The company had revenue of $73.79 billion for the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. Cigna Group’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $7.83 EPS. On average, sell-side analysts expect that Cigna Group will post 30.71 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s payout ratio is presently 27.54%.

Insider Buying and Selling at Cigna Group

In other news, insider Everett Neville sold 617 shares of the company’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Mystic Asset Management Inc. purchased a new stake in Cigna Group in the second quarter valued at approximately $2,808,000. KBC Group NV lifted its stake in Cigna Group by 6.4% during the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after acquiring an additional 22,978 shares during the period. Nykredit A S purchased a new stake in shares of Cigna Group in the 2nd quarter valued at $15,300,000. Sanctuary Advisors LLC purchased a new stake in shares of Cigna Group in the 2nd quarter valued at $11,043,000. Finally, TD Asset Management Inc increased its stake in shares of Cigna Group by 4.8% in the second quarter. TD Asset Management Inc now owns 249,966 shares of the health services provider’s stock worth $68,911,000 after acquiring an additional 11,471 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Company Profile

(Get Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

Further Reading

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.